StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$91.54−5.96 (-6.11%)

Close on Nov 18, 2026Market cap $4.32BP/E –Yield –

BillionToOne net income

Net income is the profit left for shareholders after every expense, interest and tax.

BillionToOne's net income for the twelve months ending Sep 30, 2026 was $49.39M. For fiscal 2025 it was $7.45M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.45M–
FY2024Dec 31, 2024-$41.57M–
FY2023Dec 31, 2023-$82.68M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$17.39M+204.5%
Q2 FY2026Jun 30, 2026$8.05M–
Q1 FY2026Mar 31, 2026$17.97M–
Q4 FY2025Dec 31, 2025$5.98M–
Q3 FY2025Sep 30, 2025$5.71M–
Q2 FY2025Jun 30, 2025-$246.00K–
Q1 FY2025Mar 31, 2025-$3.99M–
Q4 FY2024Dec 31, 2024-$11.48M–
Q3 FY2024Sep 30, 2024-$14.90M–

More BillionToOne figures

See a number that looks wrong?